Literature DB >> 24011577

Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease?

Yi-An Ko1, Katalin Susztak.   

Abstract

Epigenetics refers to functionally relevant modifications of the genome that do not involve a change in the nucleotide sequence. Examples of such modifications are DNA methylation and histone modifications. Both modifications serve to regulate gene expression without altering the underlying DNA sequence. The epigenome encodes critical information to regulate gene expression. The cellular epigenome is established during development and differentiation and maintained during cell division. These instructions are different in each cell type; therefore, the epigenome is cell-type-specific. Nutrient availability and other environmental factors cause changes in the epigenome. Recent research suggests the critical contribution of the epigenome to the development of complex gene-environmental diseases including chronic kidney diseases. Published by Elsevier Inc.

Entities:  

Keywords:  Kidney; cytosine methylation; enhancer; epigenetics; histones

Mesh:

Substances:

Year:  2013        PMID: 24011577      PMCID: PMC3815533          DOI: 10.1016/j.semnephrol.2013.05.007

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  60 in total

1.  Sequentially acting Sox transcription factors in neural lineage development.

Authors:  Maria Bergsland; Daniel Ramsköld; Cécile Zaouter; Susanne Klum; Rickard Sandberg; Jonas Muhr
Journal:  Genes Dev       Date:  2011-11-15       Impact factor: 11.361

2.  Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

Authors:  Adrian P Bracken; Nikolaj Dietrich; Diego Pasini; Klaus H Hansen; Kristian Helin
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

3.  Polycomb complexes repress developmental regulators in murine embryonic stem cells.

Authors:  Laurie A Boyer; Kathrin Plath; Julia Zeitlinger; Tobias Brambrink; Lea A Medeiros; Tong Ihn Lee; Stuart S Levine; Marius Wernig; Adriana Tajonar; Mridula K Ray; George W Bell; Arie P Otte; Miguel Vidal; David K Gifford; Richard A Young; Rudolf Jaenisch
Journal:  Nature       Date:  2006-04-19       Impact factor: 49.962

4.  Control of developmental regulators by Polycomb in human embryonic stem cells.

Authors:  Tong Ihn Lee; Richard G Jenner; Laurie A Boyer; Matthew G Guenther; Stuart S Levine; Roshan M Kumar; Brett Chevalier; Sarah E Johnstone; Megan F Cole; Kyo-ichi Isono; Haruhiko Koseki; Takuya Fuchikami; Kuniya Abe; Heather L Murray; Jacob P Zucker; Bingbing Yuan; George W Bell; Elizabeth Herbolsheimer; Nancy M Hannett; Kaiming Sun; Duncan T Odom; Arie P Otte; Thomas L Volkert; David P Bartel; Douglas A Melton; David K Gifford; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

5.  Cardiovascular disease in survivors of the Dutch famine.

Authors:  Anita C J Ravelli; Otto P Bleker; Tessa J Roseboom; Gert A van Montfrans; Clive Osmond; David J P Barker
Journal:  Nestle Nutr Workshop Ser Pediatr Program       Date:  2005

6.  A bivalent chromatin structure marks key developmental genes in embryonic stem cells.

Authors:  Bradley E Bernstein; Tarjei S Mikkelsen; Xiaohui Xie; Michael Kamal; Dana J Huebert; James Cuff; Ben Fry; Alex Meissner; Marius Wernig; Kathrin Plath; Rudolf Jaenisch; Alexandre Wagschal; Robert Feil; Stuart L Schreiber; Eric S Lander
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

7.  G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis.

Authors:  Nirit Feldman; Ariela Gerson; Jia Fang; En Li; Yi Zhang; Yoichi Shinkai; Howard Cedar; Yehudit Bergman
Journal:  Nat Cell Biol       Date:  2006-01-15       Impact factor: 28.824

8.  Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus.

Authors:  R G Nelson; H Morgenstern; P H Bennett
Journal:  Am J Epidemiol       Date:  1998-10-01       Impact factor: 4.897

9.  Chromatin signatures of pluripotent cell lines.

Authors:  Véronique Azuara; Pascale Perry; Stephan Sauer; Mikhail Spivakov; Helle F Jørgensen; Rosalind M John; Mina Gouti; Miguel Casanova; Gary Warnes; Matthias Merkenschlager; Amanda G Fisher
Journal:  Nat Cell Biol       Date:  2006-03-29       Impact factor: 28.824

10.  Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks.

Authors:  Anne Schellenberg; Qiong Lin; Herdit Schüler; Carmen M Koch; Sylvia Joussen; Bernd Denecke; Gudrun Walenda; Norbert Pallua; Christoph V Suschek; Martin Zenke; Wolfga Wagner
Journal:  Aging (Albany NY)       Date:  2011-09       Impact factor: 5.682

View more
  11 in total

1.  The hyperglycemic and hyperinsulinemic combo gives you diabetic kidney disease immediately. Focus on "Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney".

Authors:  Seung Hyeok Han; Katalin Susztak
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

Review 2.  Understanding the epigenetic syntax for the genetic alphabet in the kidney.

Authors:  Katalin Susztak
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

Review 3.  The role of epigenetics in renal ageing.

Authors:  Paul G Shiels; Dagmara McGuinness; Maria Eriksson; Jeroen P Kooman; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2017-06-19       Impact factor: 28.314

Review 4.  Epigenetics: a new way to look at kidney diseases.

Authors:  Pazit Beckerman; Yi-An Ko; Katalin Susztak
Journal:  Nephrol Dial Transplant       Date:  2014-03-27       Impact factor: 5.992

5.  MIAOME: Human microbiome affect the host epigenome.

Authors:  Lidan Wang; Wei Zhang; Xianglu Wu; Xiao Liang; Lijie Cao; Jincheng Zhai; Yiyang Yang; Qiuxiao Chen; Hongqing Liu; Jun Zhang; Yubin Ding; Feng Zhu; Jing Tang
Journal:  Comput Struct Biotechnol J       Date:  2022-05-17       Impact factor: 6.155

Review 6.  Cytosine Methylation Studies in Patients with Diabetic Kidney Disease.

Authors:  Tamas Aranyi; Katalin Susztak
Journal:  Curr Diab Rep       Date:  2019-08-30       Impact factor: 4.810

Review 7.  Molecular mechanisms of diabetic kidney disease.

Authors:  Kimberly Reidy; Hyun Mi Kang; Thomas Hostetter; Katalin Susztak
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

Review 8.  Recent developments in epigenetics of acute and chronic kidney diseases.

Authors:  Marpadga A Reddy; Rama Natarajan
Journal:  Kidney Int       Date:  2015-05-20       Impact factor: 10.612

9.  The most common technologies and tools for functional genome analysis.

Authors:  Evelina Gasperskaja; Vaidutis Kučinskas
Journal:  Acta Med Litu       Date:  2017

Review 10.  Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome.

Authors:  Ashani Lecamwasam; Elif I Ekinci; Richard Saffery; Karen M Dwyer
Journal:  Biomedicines       Date:  2020-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.